scholarly journals Macrophage migration inhibitory factor: Roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma

2003 ◽  
Vol 107 (1) ◽  
pp. 22-29 ◽  
Author(s):  
Yi Ren ◽  
Hong-Teng Tsui ◽  
Ronnie Tung-Ping Poon ◽  
Irene Oi-Lin Ng ◽  
Zhi Li ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Cell Migration ◽  
Tumor Cell ◽  
Migration Inhibitory Factor ◽  
Macrophage Migration Inhibitory Factor ◽  
Angiogenic Factors ◽  
Inhibitory Factor ◽  
Macrophage Migration ◽  
Tumor Cell Migration

Macrophage migration inhibitory factor in hepatocellular carcinoma and liver cirrhosis; relevance to pathogenesis

2001 ◽  
Vol 171 (2) ◽  
pp. 125-132 ◽  
Author(s):  
S.M.Fazle Akbar ◽  
Masanori Abe ◽  
Hidehiro Murakami ◽  
Kenji Tanimoto ◽  
Teru Kumagi ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Cirrhosis ◽  
Migration Inhibitory Factor ◽  
Macrophage Migration Inhibitory Factor ◽  
Inhibitory Factor ◽  
Macrophage Migration

scholarly journals Macrophage migration inhibitory factor exerts pro-proliferative and anti-apoptotic effects via CD74 in murine hepatocellular carcinoma

2020 ◽  
Author(s):  
Theresa Wirtz ◽  
Alena Saal ◽  
Irina Bergmann ◽  
Petra Fischer ◽  
Daniel Heinrichs ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Migration Inhibitory Factor ◽  
Macrophage Migration Inhibitory Factor ◽  
Inhibitory Factor ◽  
Surrounding Tissue ◽  
Macrophage Migration ◽  
Tumour Burden ◽  
The Impact

Background and Purpose: Macrophage migration inhibitory factor (MIF) is an inflammatory and chemokine-like protein expressed in different diseases as well as solid tumours. Here, CD74 – as the cognate MIF receptor – was identified as an important target of MIF. We analysed the role of MIF and CD74 in the progression of hepatocellular carcinoma (HCC) in vitro and in vivo using an experimental murine HCC model. Experimental Approach: Multilocular HCC was induced using the diethylnitrosamine/carbon tetrachloride (DEN/CCl4) model in hepatocyte-specific Mif knockout (Mif Δhep), CD74-deficient, and control mice. Tumour burden was compared between the genotypes. MIF, CD74 and Ki67 expression were investigated in tumour and surrounding tissue. In vitro, the impact of the MIF/CD74 axis on the proliferative and apoptotic behaviour of hepatoma cells was assessed after stimulation with MIF and anti-CD74 antibodies. Key Results: DEN/CCl4 treatment of Mif Δhep mice resulted in reduced tumour burden and diminished proliferation capacity within the tumour tissue. In vitro, MIF stimulated the proliferation of Hepa 1-6 cells and inhibited therapy-induced cell death as evidenced by TUNEL-staining. Both effects could be reversed using a neutralizing anti-CD74 antibody, and Cd74-/- mice developed fewer tumours associated with decreased proliferation rates. Conclusion and Implications: In this study, we identified a pro-tumorigenic role of MIF during proliferation and therapy-induced apoptosis of HCC cells. Furthermore, our study implicates that these effects are mediated via the MIF cognate receptor CD74. In conclusion, the inhibition of the MIF/CD74 axis could present a promising target with regard to prospective HCC-directed pharmacological therapies.

scholarly journals Involvement of Macrophage Migration Inhibitory Factor (MIF) in the Mechanism of Tumor Cell Growth

1998 ◽  
Vol 4 (11) ◽  
pp. 707-714 ◽  
Author(s):  
Norihiko Takahashi ◽  
Jun Nishihira ◽  
Yuji Sato ◽  
Masao Kondo ◽  
Hideaki Ogawa ◽  
...  
Keyword(s):  
Cell Growth ◽  
Tumor Cell ◽  
Migration Inhibitory Factor ◽  
Macrophage Migration Inhibitory Factor ◽  
Inhibitory Factor ◽  
Macrophage Migration ◽  
Tumor Cell Growth
Sign in / Sign up

Export Citation Format

Share Document